TCI Wealth Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
TCI Wealth Advisors's ANGO Position: Q2 2022 in Review
TCI Wealth Advisors sold out of AngioDynamics (ANGO) in Q2 2022, closing a stake of 163 shares — an estimated $4K sold.
TCI Wealth Advisors first reported a position in ANGO in Q1 2016 and held it in 21 quarters. The position peaked at $9K in Q4 2021. 134 funds tracked by Wall St. Rank hold ANGO as of Q2 2022.
- TCI Wealth Advisors reported no remaining AngioDynamics position as of Q2 2022 after selling out during the quarter.
- TCI Wealth Advisors sold 163 AngioDynamics shares in Q2 2022, an estimated $4K.
- TCI Wealth Advisors first reported a position in AngioDynamics in Q1 2016 and held it in 21 quarters.
- TCI Wealth Advisors's AngioDynamics position peaked at $9K in Q4 2021.
- 134 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2022.
Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.